Ann: Trading Halt, page-43

So just adding to my previous post to clarify where I'm coming from.....

Although the trading halt is in relation to the 'acquisition of a dermatology asset'......this could mean either BOT themselves are acquiring a
dermatology asset (which they have said they have been looking at doing recently)...

OR .....It could mean some one else (like Pfizer or some other big hitter) is interested or acquiring a 'dermatology asset' from BOT (In full or in part) ie. limited rights to use BOT Permatrex system for a specific product they have to help make their product more effective.

The halt announcement seems very vague - but is probably required to be vague when making any trading halt to the ASX.

Eitherway.......this pending announcement has got to be good I think. (the later scenario would be more awesome obviously) Get that patented delivery system working for us to bring in the $$.

Just my thoughts.